Table 4 Synergistic antifungal activity of ZnO-NPs with conventional antifungals against C. albicans and C. tropicalis. Data represent mean Inhibition zone diameters (mm ± SE, *n* = 3). Superscript letters (ᵃ, ᵇ) indicate statistical significance within columns (Tukey’s test, *p* < 0.05). IFA = Increase in fold area; ns = not significant (p ≥ 0.05). FICI (Fractional inhibitory concentration Index) interpretation: ≤0.5 synergistic, > 0.5–1.0 additive, > 1.0–4.0 indifferent, > 4.0 antagonistic.
A. C. albicans | ||||||
---|---|---|---|---|---|---|
Treatment | Ketoconazole | Fluconazole | Itraconazole | Nystatin | Terbinafine | Amphotericin B |
Antifungal only | 16.35 ± 0.41ᵃ | 17.93 ± 0.29ᵃ | 16.34 ± 0.54ᵃ | 27.13 ± 0.51ᵃ | 26.38 ± 0.51ᵃ | 11.82 ± 0.58ᵃ |
Antifungal + ZnONPs | 19.83 ± 0.25ᵃ | 22.81 ± 0.38ᵇ | 17.15 ± 0.42ᵃ | 36.92 ± 0.32ᵇ | 35.14 ± 0.63ᵇ | 12.45 ± 0.51ᵃ |
IFA | 0.47 | 0.62 | 0.10 | 0.85 | 0.77 | 0.11 |
P value | NS | 0.0426 | NS | 0.0017 | 0.0031 | NS |
FICI | 1.25 | 0.75 | 1.50 | 0.38 | 0.63 | 1.50 |
Interpretation | Indifferent | Additive | Indifferent | Synergistic | Additive | Indifferent |
B. C. tropicalis | ||||||
Treatment Ketoconazole Fluconazole Itraconazole Nystatin Terbinafine Amphotericin B | ||||||
Antifungal only | 15.82 ± 0.57a | 25.73 ± 0.35a | 21.63 ± 0.54a | 16.84 ± 0.46a | 38.64 ± 0.74a | 13.52 ± 0.42a |
Antifungal + ZnONPs | 21.09 ± 0.21b | 34.38 ± 0.62b | 22.43 ± 0.32a | 23.78 ± 0.38b | 37.92 ± 0.32a | 16.97 ± 0.31a |
IFA | 0.78 | 0.79 | 0.07 | 0.99 | − 0.04 | 0.58 |
P value | 0.0316 | 0.0011 | NS | 0.0096 | NS | NS |
FICI | 0.75 | 0.63 | 1.25 | 0.25 | 4.00 | 1.25 |
Interpretation | Additive | Additive | Indifferent | Synergistic | Antagonistic | In different |